MA47687A - ADENO-ASSOCIATED VIRUS (AAV) CLADE F VECTOR AND ITS USES - Google Patents
ADENO-ASSOCIATED VIRUS (AAV) CLADE F VECTOR AND ITS USESInfo
- Publication number
- MA47687A MA47687A MA047687A MA47687A MA47687A MA 47687 A MA47687 A MA 47687A MA 047687 A MA047687 A MA 047687A MA 47687 A MA47687 A MA 47687A MA 47687 A MA47687 A MA 47687A
- Authority
- MA
- Morocco
- Prior art keywords
- clade
- aav
- adeno
- vector
- associated virus
- Prior art date
Links
- 241000702421 Dependoparvovirus Species 0.000 title 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/761—Adenovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762464748P | 2017-02-28 | 2017-02-28 | |
PCT/US2018/019992 WO2018160582A1 (en) | 2017-02-28 | 2018-02-27 | Adeno-associated virus (aav) clade f vector and uses therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
MA47687A true MA47687A (en) | 2021-03-31 |
MA47687B1 MA47687B1 (en) | 2024-03-29 |
Family
ID=91034127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA47687A MA47687B1 (en) | 2017-02-28 | 2018-02-27 | CLADE F ADENO-ASSOCIATED VIRUS VECTORS, AND THEIR USES |
Country Status (1)
Country | Link |
---|---|
MA (1) | MA47687B1 (en) |
-
2018
- 2018-02-27 MA MA47687A patent/MA47687B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA47687B1 (en) | 2024-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201905407B (en) | Adeno-associated virus (aav) clade f vector and uses therefor | |
DK3684423T3 (en) | Adeno-associated virus variant capsids and methods of using the same | |
MA50502A (en) | ADENOVIRUS AND RELATED USES | |
IL263801B1 (en) | Novel adeno-associated virus capsid proteins | |
DK3445773T3 (en) | Adeno-associated virus variant capsids and methods of using the same | |
DK3472183T5 (en) | VARIANT ADENO-ASSOCIATED VIRUSES AND METHODS OF USE | |
EP3364996A4 (en) | Prostate-targeting adeno-associated virus serotype vectors | |
TR201901582T4 (en) | Capsid | |
EP3528785A4 (en) | Modified aav capsids and uses thereof | |
EP3585883A4 (en) | Modified aav capsid proteins and uses thereof | |
FR3021319B1 (en) | PEPTIDES, COMPOSITIONS COMPRISING THE SAME, AND PARTICULARLY COSMETIC USES | |
EP3368054A4 (en) | Regulatable expression using adeno-associated virus (aav) | |
EP3262162A4 (en) | Regulatable expression using adeno-associated virus (aav) | |
HK1222673A1 (en) | Aav vector and assay for anti-aav (adeno-associated virus) neutralizing antibodies aav aav() | |
EA201791562A1 (en) | CYTOMEGALOVIRUS ANTIGENS AND THEIR APPLICATIONS | |
EP3221456A4 (en) | Genome-modified recombinant adeno-associated virus vectors | |
IL282053A (en) | Recombinant glut1 adeno-associated viral vector constructs , compositions and kits comprising the same and use thereof | |
DK3442600T3 (en) | ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF ß-SARCOGLYCAN AND MICRORNA-29 AND THE TREATMENT OF MUSCULAR DYSTROPHY | |
IL272972A (en) | Adeno-associated virus (aav) with modified phospholipase domain | |
IL253103A0 (en) | Adeno-associated virus vectors encoding modified g6pc and uses thereof | |
FI11890U1 (en) | POINT TYPE INPUT | |
SG11201704919SA (en) | Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav) | |
FR3035590B1 (en) | BIOASSIMILABLE PROTEOMELANIC COMPLEX, PREPARATION AND USES | |
MA47687A (en) | ADENO-ASSOCIATED VIRUS (AAV) CLADE F VECTOR AND ITS USES | |
MA44484A (en) | PROTEINOPATHY BIOMARKERS AND ASSOCIATED USES |